products for prevention
deCODE genetics has developed a range of diagnostic risk assessment tests to enable physicians and other authorized healthcare providers, to empower their patients with state of the art knowledge about genetic predispositions to a range of common disease and traits. The deCODE diagnostic tests for 6 common diseases, such as MI, Type2Diabetes, are reimbursed by many health insurance companies in the U.S. and therefore only offered through physicians and authorized healthcare professionals. Please contact us for further information.
Genetic scans
deCODE Complete Scan analyses genetic risk factors for 50 diseases ranging from heart attack and diabetes to lung cancer and traits like ABO bloodtypes, eye color and male pattern baldness.
deCODE Cancer Scan analyzes your genetic variants and outlines your risk for seven of the most common cancers, including breast cancer for women and prostate cancer for men.
deCODE Cardio Scan assesses your genetic risk for various cardiovascular diseases like heart attack and atrial fibrillation, generally referred to as heart disease.
Our diagnostic tests
deCODE T2 defines genetic risk for T2D, independent of family history and obesity. By knowing and understanding the genetic risk, it may be possible to take actions that reduce or minimize the likelihood of an individual developing diabetes.
deCODE MI detects previously unrecognized genetic risk of MI that appears to be in addition to welll known risk factors such as elevated cholesterol and hypertension. The test may be positive even in patients of families without history of heart attacks.
deCODE BreastCancer is a reference laboratory DNA test for assessing individual risk of the common forms of breast cancer. The common forms of the disease account for approximately 95% of all breast cancers.
deCODE AF offers a novel means of identifying those who may benefit from outpatient cardiac monitoring after leaving the hospital.
deCODE ProstateCancer is a reference laboratory DNA test for assessing an inherited risk factor for Prostate Cancer.
deCODE Glaucoma is a reference laboratory DNA test for assessing an inherited risk factor for exfoliation glaucoma.